# OnCo record buserelin (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/buserelin/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "buserelin" ;
  schema:name "Buserelin"@en ;
  schema:description "Buserelin is one of the original GnRH agonists, approved in Europe and Canada in the 1980s for advanced prostate cancer and also used in endometriosis and fertility treatment; it is not sold in the United States."@en ;
  schema:url <https://onco.cc/drugs/buserelin/> ;
  schema:dateModified "2026-09-08"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Buserelin> ;
  schema:citation <https://en.wikipedia.org/wiki/Buserelin>, <https://www.ebi.ac.uk/chembl/explore/compound/CHEMBL1201248> ;
  onco:status "established" ;
  onco:tag "gap-fill", "chembl-universe" ;
  onco:modality "GnRH agonist, injection or nasal spray" ;
  schema:alternateName "Suprefact" ;
  onco:cancers <https://onco.cc/cancers/prostate/> ;
  onco:technologies <https://onco.cc/technologies/endocrine-therapy/> ;
  onco:targets <https://onco.cc/targets/gnrhr/> ;
  onco:drugs <https://onco.cc/drugs/leuprolide/>, <https://onco.cc/drugs/goserelin/>, <https://onco.cc/drugs/triptorelin/> ;
  onco:companies <https://onco.cc/companies/sanofi/> ;
  onco:trials <https://onco.cc/trials/nct04513717/>, <https://onco.cc/trials/nct00567580/>, <https://onco.cc/trials/nct00936390/> .